Related Experiment Video
Updated: Oct 16, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
COVID-19 in Patients with Active Tuberculosis.
Monika Kozińska1, Ewa Augustynowicz-Kopeć1
1Department of Microbiology, National Tuberculosis and Lung Diseases Research Institute, Plocka 26, 01-138 Warsaw, Poland.
Coinfection with tuberculosis (TB) and COVID-19 presents varied outcomes, with one patient experiencing fatal respiratory failure and another recovering despite multiple health issues. This highlights the vulnerability of disadvantaged populations to coinfections.
Area of Science:
- Infectious Diseases
- Public Health
- Epidemiology
Background:
- Limited data exists on tuberculosis (TB) and COVID-19 coinfection, leading to polarized views on SARS-CoV-2 outcomes in active TB patients.
- This study presents the first documented cases of TB and COVID-19 coinfection in Poland following the pandemic's onset.
Observation:
- Two cases of TB and COVID-19 coinfection were observed in individuals from a homeless shelter.
- The first patient, with advanced TB, developed severe respiratory failure and died. The second patient, with coexisting HIV and TB (pulmonary and extrapulmonary), experienced mild, asymptomatic SARS-CoV-2 infection and achieved therapeutic success despite renal failure.
Findings:
- Molecular epidemiological investigation ruled out TB transmission between the two patients.
- The study could not definitively establish the impact of active TB on SARS-CoV-2 infection severity.
- Coinfection appears particularly dangerous for socially disadvantaged individuals, the elderly, and those with comorbidities.
Implications:
- The global COVID-19 pandemic is expected to negatively impact control programs for infectious diseases, including TB.
- Further research is needed to understand the complex interactions between TB and SARS-CoV-2.
- Targeted interventions and support are crucial for vulnerable populations facing coinfections.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

